Dhanuka Agritech faces monsoon pressure as Nagpur plant expands capacity

Q1FY27 Performance: Weather Disrupts Agrochemical Demand

Dhanuka Agritech reported a weak Q1FY27, with performance affected by adverse weather and a delayed monsoon onset. Delayed sowing in key kharif crops reduced agrochemical demand, particularly during the peak herbicide season for soyabean and cotton in western and central India.

The EBITDA margin contracted to 11.9% from 15.7% in Q1FY26. The decline reflected an 87-basis-point increase in raw-material cost as a proportion of sales, along with operating-cost deleverage. Royalty expense fell significantly year-on-year to Rs 40 million.

Herbicide and Regional Weakness

Herbicide revenue declined 26.6% year-on-year to Rs 1,940 million, making the segment the principal area affected by the weather-related demand disruption. West India sales also declined, with pressure reported across western and central crop markets.

Nagpur Formulation Plant to Expand Capacity

Dhanuka Agritech has acquired land at Butibori near Nagpur for a greenfield formulation plant. The facility will have an initial capacity of 23,000 MT per annum and involves a capital outlay of Rs 2,000 million. More than Rs 1,000 million is expected to be spent in each of FY27 and FY28, with commissioning expected in Q1FY29.

According to Elara, the Nagpur location will separate formulation operations from chemical synthesis at Dahej. It is centrally located in the Deccan plateau agricultural region, offers scope for capacity expansion and carries CGST benefits from the Maharashtra government.

Dahej Synthesis Plant Remains Below Breakeven

The Dahej technical synthesis plant reported Q1FY27 revenue of Rs 260 million, compared with Rs 160 million in Q1FY26. Its EBITDA loss narrowed to about Rs 10 million from Rs 30 million. However, Elara expects FY27 revenue of Rs 650 million, compared with Rs 500 million in the previous year, as Q1 captures peak-season offtake and demand is expected to reduce in H2.

The broker expects full-year EBITDA at Dahej to remain negative, with breakeven still difficult.

Revised Estimates and Valuation

Elara has introduced FY29 estimates and cut its FY27E and FY28E forecasts. Revenue estimates were reduced by 4.0% and 5.6%, respectively; EBITDA estimates were cut by 7.4% and 9.4%; and PAT estimates were lowered by 5.7% and 8.1%.

Elara maintains its Buy recommendation but lowers the target price to Rs 1,240 from Rs 1,372, with a holding horizon of more than nine months. The broker considers the stock’s valuation of 12 times Q1FY29E EPS compelling. The target price is based on 15 times Q1FY29E EPS in the report narrative.

Key Risk: Continued Monsoon Weakness

Elara warns that a continued adverse monsoon could lead to near-term underperformance because agrochemical consumption is weather-sensitive. The delayed monsoon and sowing disruption have already affected demand, particularly in herbicides and in western and central crop markets.